HEADER TRANSFERASE 11-JAN-16 5HHW TITLE CRYSTAL STRUCTURE OF INSULIN RECEPTOR KINASE DOMAIN IN COMPLEX WITH TITLE 2 CIS-(R)-7-(3-(AZETIDIN-1-YLMETHYL)CYCLOBUTYL)-5-(3-((TETRAHYDRO-2H- TITLE 3 PYRAN-2-YL)METHOXY)PHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 1005-1310; COMPND 5 SYNONYM: IR; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: INSR; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS INHIBITOR, COMPLEX, INSULIN RECEPTOR, KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.SCHEUFLER,A.IZAAC,F.STAUFFER REVDAT 3 01-MAY-24 5HHW 1 REMARK REVDAT 2 24-JAN-18 5HHW 1 SOURCE REVDAT 1 13-APR-16 5HHW 0 JRNL AUTH F.STAUFFER,S.W.COWAN-JACOB,C.SCHEUFLER,P.FURET JRNL TITL IDENTIFICATION OF A JRNL TITL 2 5-[3-PHENYL-(2-CYCLIC-ETHER)-METHYLETHER]-4-AMINOPYRROLO[2, JRNL TITL 3 3-D]PYRIMIDINE SERIES OF IGF-1R INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 26 2065 2016 JRNL REFN ESSN 1464-3405 JRNL PMID 26951750 JRNL DOI 10.1016/J.BMCL.2016.02.074 REMARK 2 REMARK 2 RESOLUTION. 1.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.77 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 87.1 REMARK 3 NUMBER OF REFLECTIONS : 30248 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.172 REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.198 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1513 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.85 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.12 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3372 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1877 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3203 REMARK 3 BIN R VALUE (WORKING SET) : 0.1856 REMARK 3 BIN FREE R VALUE : 0.2274 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.01 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 169 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2418 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 320 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.39 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.70860 REMARK 3 B22 (A**2) : 1.18830 REMARK 3 B33 (A**2) : -1.89690 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.184 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.133 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.117 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.122 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.112 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2545 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3451 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 891 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 63 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 367 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2545 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 314 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3262 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.95 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.43 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.12 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* L|* } REMARK 3 ORIGIN FOR THE GROUP (A): -14.3489 -15.4953 18.2125 REMARK 3 T TENSOR REMARK 3 T11: -0.0479 T22: -0.0443 REMARK 3 T33: -0.0366 T12: -0.0016 REMARK 3 T13: -0.0126 T23: 0.0013 REMARK 3 L TENSOR REMARK 3 L11: 0.4869 L22: 0.8499 REMARK 3 L33: 0.6406 L12: -0.2621 REMARK 3 L13: -0.1932 L23: 0.1153 REMARK 3 S TENSOR REMARK 3 S11: -0.0384 S12: -0.0247 S13: 0.0008 REMARK 3 S21: 0.0338 S22: 0.0176 S23: 0.0399 REMARK 3 S31: 0.0330 S32: 0.0221 S33: 0.0208 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5HHW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-JAN-16. REMARK 100 THE DEPOSITION ID IS D_1000217056. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-APR-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30264 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.1 REMARK 200 DATA REDUNDANCY : 7.160 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06000 REMARK 200 FOR THE DATA SET : 24.2800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 0.36000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.820 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: INHOUSE MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% PEG3000, 0.1M TRIS PH7.5, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.96000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.93000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.58000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.93000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.96000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.58000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1004 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A1061 CG CD OE1 OE2 REMARK 470 SER A1062 OG REMARK 470 GLU A1123 CG CD OE1 OE2 REMARK 470 MET A1180 CG SD CE REMARK 470 LYS A1195 CG CD CE NZ REMARK 470 ARG A1270 CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A1013 97.38 -68.88 REMARK 500 ASP A1014 -144.27 -121.53 REMARK 500 PHE A1034 -39.71 76.47 REMARK 500 LYS A1154 30.02 73.92 REMARK 500 ARG A1158 -13.24 75.15 REMARK 500 ASN A1159 31.24 -140.26 REMARK 500 LYS A1195 -10.18 -144.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 60O A 1401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 1402 DBREF 5HHW A 1005 1310 UNP P06213 INSR_HUMAN 1005 1310 SEQADV 5HHW MET A 1004 UNP P06213 INITIATING METHIONINE SEQADV 5HHW SER A 1008 UNP P06213 CYS 1008 ENGINEERED MUTATION SEQADV 5HHW ASN A 1159 UNP P06213 ASP 1159 ENGINEERED MUTATION SEQRES 1 A 307 MET VAL PHE PRO SER SER VAL TYR VAL PRO ASP GLU TRP SEQRES 2 A 307 GLU VAL SER ARG GLU LYS ILE THR LEU LEU ARG GLU LEU SEQRES 3 A 307 GLY GLN GLY SER PHE GLY MET VAL TYR GLU GLY ASN ALA SEQRES 4 A 307 ARG ASP ILE ILE LYS GLY GLU ALA GLU THR ARG VAL ALA SEQRES 5 A 307 VAL LYS THR VAL ASN GLU SER ALA SER LEU ARG GLU ARG SEQRES 6 A 307 ILE GLU PHE LEU ASN GLU ALA SER VAL MET LYS GLY PHE SEQRES 7 A 307 THR CYS HIS HIS VAL VAL ARG LEU LEU GLY VAL VAL SER SEQRES 8 A 307 LYS GLY GLN PRO THR LEU VAL VAL MET GLU LEU MET ALA SEQRES 9 A 307 HIS GLY ASP LEU LYS SER TYR LEU ARG SER LEU ARG PRO SEQRES 10 A 307 GLU ALA GLU ASN ASN PRO GLY ARG PRO PRO PRO THR LEU SEQRES 11 A 307 GLN GLU MET ILE GLN MET ALA ALA GLU ILE ALA ASP GLY SEQRES 12 A 307 MET ALA TYR LEU ASN ALA LYS LYS PHE VAL HIS ARG ASN SEQRES 13 A 307 LEU ALA ALA ARG ASN CYS MET VAL ALA HIS ASP PHE THR SEQRES 14 A 307 VAL LYS ILE GLY ASP PHE GLY MET THR ARG ASP ILE TYR SEQRES 15 A 307 GLU THR ASP TYR TYR ARG LYS GLY GLY LYS GLY LEU LEU SEQRES 16 A 307 PRO VAL ARG TRP MET ALA PRO GLU SER LEU LYS ASP GLY SEQRES 17 A 307 VAL PHE THR THR SER SER ASP MET TRP SER PHE GLY VAL SEQRES 18 A 307 VAL LEU TRP GLU ILE THR SER LEU ALA GLU GLN PRO TYR SEQRES 19 A 307 GLN GLY LEU SER ASN GLU GLN VAL LEU LYS PHE VAL MET SEQRES 20 A 307 ASP GLY GLY TYR LEU ASP GLN PRO ASP ASN CYS PRO GLU SEQRES 21 A 307 ARG VAL THR ASP LEU MET ARG MET CYS TRP GLN PHE ASN SEQRES 22 A 307 PRO LYS MET ARG PRO THR PHE LEU GLU ILE VAL ASN LEU SEQRES 23 A 307 LEU LYS ASP ASP LEU HIS PRO SER PHE PRO GLU VAL SER SEQRES 24 A 307 PHE PHE HIS SER GLU GLU ASN LYS HET 60O A1401 33 HET EDO A1402 4 HETNAM 60O 7-[3-(AZETIDIN-1-YLMETHYL)CYCLOBUTYL]-5-[3-[[(2~{R})- HETNAM 2 60O OXAN-2-YL]METHOXY]PHENYL]PYRROLO[2,3-D]PYRIMIDIN-4- HETNAM 3 60O AMINE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 2 60O C26 H33 N5 O2 FORMUL 3 EDO C2 H6 O2 FORMUL 4 HOH *320(H2 O) HELIX 1 AA1 SER A 1019 GLU A 1021 5 3 HELIX 2 AA2 SER A 1064 LYS A 1079 1 16 HELIX 3 AA3 ASP A 1110 LEU A 1118 1 9 HELIX 4 AA4 THR A 1132 LYS A 1153 1 22 HELIX 5 AA5 PRO A 1199 MET A 1203 5 5 HELIX 6 AA6 ALA A 1204 GLY A 1211 1 8 HELIX 7 AA7 THR A 1214 LEU A 1232 1 19 HELIX 8 AA8 SER A 1241 ASP A 1251 1 11 HELIX 9 AA9 PRO A 1262 TRP A 1273 1 12 HELIX 10 AB1 ASN A 1276 ARG A 1280 5 5 HELIX 11 AB2 THR A 1282 LYS A 1291 1 10 HELIX 12 AB3 ASP A 1292 LEU A 1294 5 3 HELIX 13 AB4 SER A 1297 SER A 1302 1 6 SHEET 1 AA1 5 ILE A1023 GLN A1031 0 SHEET 2 AA1 5 MET A1036 ILE A1046 -1 O VAL A1037 N LEU A1029 SHEET 3 AA1 5 GLU A1049 THR A1058 -1 O VAL A1054 N GLY A1040 SHEET 4 AA1 5 LEU A1100 GLU A1104 -1 O MET A1103 N ALA A1055 SHEET 5 AA1 5 LEU A1089 VAL A1093 -1 N LEU A1090 O VAL A1102 SHEET 1 AA2 2 CYS A1165 VAL A1167 0 SHEET 2 AA2 2 VAL A1173 ILE A1175 -1 O LYS A1174 N MET A1166 SHEET 1 AA3 2 TYR A1190 LYS A1192 0 SHEET 2 AA3 2 GLY A1196 LEU A1198 -1 O LEU A1198 N TYR A1190 CISPEP 1 GLN A 1097 PRO A 1098 0 1.51 SITE 1 AC1 17 LEU A1029 GLY A1030 GLN A1031 SER A1033 SITE 2 AC1 17 PHE A1034 ALA A1055 LYS A1057 MET A1078 SITE 3 AC1 17 VAL A1087 MET A1103 GLU A1104 MET A1106 SITE 4 AC1 17 ASP A1110 ARG A1163 MET A1166 ASP A1177 SITE 5 AC1 17 HOH A1664 SITE 1 AC2 8 ARG A1020 ILE A1023 LEU A1025 PRO A1129 SITE 2 AC2 8 PRO A1130 HOH A1634 HOH A1670 HOH A1694 CRYST1 57.920 69.160 89.860 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017265 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014459 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011128 0.00000